SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Natalie Hirth, Marcus W. Meinhardt, Hamid R. Noori, Humberto Salgado, Oswaldo Torres-Ramirez, Stefanie Uhrig, Laura Broccoli, Valentina Vengeliene, Martin Roßmanith, Stéphanie Perreau-Lenz, Georg Köhr, Wolfgang H. Sommer, Rainer Spanagel, Anita C. Hansson, Convergent evidence from alcohol-dependent humans and rats for a hyperdopaminergic state in protracted abstinence, Proceedings of the National Academy of Sciences, 2016, 113, 11, 3024

    CrossRef

  2. 2
    Chelsea L Robertson, Kenji Ishibashi, Joy Chudzynski, Larissa J Mooney, Richard A Rawson, Brett A Dolezal, Christopher B Cooper, Amira K Brown, Mark A Mandelkern, Edythe D London, Effect of Exercise Training on Striatal Dopamine D2/D3 Receptors in Methamphetamine Users during Behavioral Treatment, Neuropsychopharmacology, 2016, 41, 6, 1629

    CrossRef

  3. 3
    Jodi J. Weinstein, Muhammad O. Chohan, Mark Slifstein, Lawrence S. Kegeles, Holly Moore, Anissa Abi-Dargham, Pathway-specific dopamine abnormalities in schizophrenia, Biological Psychiatry, 2016,

    CrossRef

  4. 4
    Kyoji Okita, Dara G. Ghahremani, Doris E. Payer, Chelsea L. Robertson, Mark A. Mandelkern, Edythe D. London, Relationship of Alexithymia Ratings to Dopamine D2-type Receptors in Anterior Cingulate and Insula of Healthy Control Subjects but Not Methamphetamine-Dependent Individuals, International Journal of Neuropsychopharmacology, 2016, 19, 5, pyv129

    CrossRef

  5. 5
    Sjoerd J. Finnema, Mika Scheinin, Mohammed Shahid, Jussi Lehto, Edilio Borroni, Benny Bang-Andersen, Jukka Sallinen, Erik Wong, Lars Farde, Christer Halldin, Sarah Grimwood, Application of cross-species PET imaging to assess neurotransmitter release in brain, Psychopharmacology, 2015, 232, 21-22, 4129

    CrossRef

  6. 6
    Sarah A. Eisenstein, Allison N. Bischoff, Danuta M. Gredysa, Jo Ann V. Antenor-Dorsey, Jonathan M. Koller, Amal Al-Lozi, Marta Y. Pepino, Samuel Klein, Joel S. Perlmutter, Stephen M. Moerlein, Kevin J. Black, Tamara Hershey, Emotional Eating Phenotype is Associated with Central Dopamine D2 Receptor Binding Independent of Body Mass Index, Scientific Reports, 2015, 5, 11283

    CrossRef

  7. 7
    M. E. Ballard, M. A. Mandelkern, J. R. Monterosso, E. Hsu, C. L. Robertson, K. Ishibashi, A. C. Dean, E. D. London, Low Dopamine D2/D3 Receptor Availability is Associated with Steep Discounting of Delayed Rewards in Methamphetamine Dependence, International Journal of Neuropsychopharmacology, 2015, 18, 7, pyu119

    CrossRef

  8. 8
    D Hernaus, D Collip, Z Kasanova, O Winz, A Heinzel, T van Amelsvoort, S M Shali, J Booij, Y Rong, M Piel, J Pruessner, F M Mottaghy, I Myin-Germeys, No evidence for attenuated stress-induced extrastriatal dopamine signaling in psychotic disorder, Translational Psychiatry, 2015, 5, 4, e547

    CrossRef

  9. 9
    D. Hernaus, M.A. Mehta, Prefrontal cortex dopamine release measured in vivo with positron emission tomography: Implications for the stimulant paradigm, NeuroImage, 2015,

    CrossRef

  10. 10
    Miho Ota, Shintaro Ogawa, Koichi Kato, Chiaki Masuda, Hiroshi Kunugi, Striatal and extrastriatal dopamine release in the common marmoset brain measured by positron emission tomography and [18F]fallypride, Neuroscience Research, 2015, 101, 1

    CrossRef

  11. 11
    J. Kambeitz, A. Abi-Dargham, S. Kapur, O. D. Howes, Alterations in cortical and extrastriatal subcortical dopamine function in schizophrenia: systematic review and meta-analysis of imaging studies, The British Journal of Psychiatry, 2014, 204, 6, 420

    CrossRef

  12. 12
    Elizabeth M. Joshi, Anne Need, John Schaus, Zhaogen Chen, Dana Benesh, Charles Mitch, Stuart Morton, Thomas J. Raub, Lee Phebus, Vanessa Barth, Efficiency Gains in Tracer Identification for Nuclear Imaging: Can In Vivo LC-MS/MS Evaluation of Small Molecules Screen for Successful PET Tracers?, ACS Chemical Neuroscience, 2014, 5, 12, 1154

    CrossRef

  13. 13
    R Narendran, H P Jedema, B J Lopresti, N S Mason, K Gurnsey, J Ruszkiewicz, C-M Chen, L Deuitch, W G Frankle, C W Bradberry, Imaging dopamine transmission in the frontal cortex: a simultaneous microdialysis and [11C]FLB 457 PET study, Molecular Psychiatry, 2014, 19, 3, 302

    CrossRef

  14. 14
    Chloe Clark-Papasavas, Joel T. Dunn, Suki Greaves, Andrew Mogg, Rosemary Gomes, Stuart Brownings, Kathy Liu, Bonnita Nwosu, Paul Marsden, John Joemon, Marcel Cleij, Robert Kessler, Robert Howard, Suzanne Reeves, Towards a therapeutic window of D2/3 occupancy for treatment of psychosis in Alzheimer's disease, with [18F]fallypride positron emission tomography, International Journal of Geriatric Psychiatry, 2014, 29, 10
  15. 15
    Robert M. Kessler, Imaging of the Human Brain in Health and Disease, 2014,

    CrossRef

  16. 16
    Lora Deuitch, Rajesh Narendran, Imaging of the Human Brain in Health and Disease, 2014,

    CrossRef

  17. 17
    N. del Campo, T. D. Fryer, Y. T. Hong, R. Smith, L. Brichard, J. Acosta-Cabronero, S. R. Chamberlain, R. Tait, D. Izquierdo, R. Regenthal, J. Dowson, J. Suckling, J.-C. Baron, F. I. Aigbirhio, T. W. Robbins, B. J. Sahakian, U. Muller, A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment, Brain, 2013, 136, 11, 3252

    CrossRef

  18. 18
    Joel T Dunn, Chloe Clark-Papasavas, Paul Marsden, Stacey Baker, Marcel Cleij, Shitij Kapur, Robert Kessler, Robert Howard, Suzanne J Reeves, Establishing test–retest reliability of an adapted [18F]fallypride imaging protocol in older people, Journal of Cerebral Blood Flow & Metabolism, 2013, 33, 7, 1098

    CrossRef

  19. 19
    Hidehiko Takahashi, PET neuroimaging of extrastriatal dopamine receptors and prefrontal cortex functions, Journal of Physiology-Paris, 2013, 107, 6, 503

    CrossRef

  20. 20
    Atsuko Nagano-Saito, Alain Dagher, Linda Booij, Paul Gravel, Krzysztof Welfeld, Kevin F. Casey, Marco Leyton, Chawki Benkelfat, Stress-induced dopamine release in human medial prefrontal cortex—18F-Fallypride/PET study in healthy volunteers, Synapse, 2013, 67, 12
  21. 21
    Ingo Vernaleken, Majken Klomp, Olaf Moeller, Mardjan Raptis, Arne Nagels, Frank Rösch, Wolfgang M. Schaefer, Paul Cumming, Gerhard Gründer, Vulnerability to psychotogenic effects of ketamine is associated with elevated D2/3-receptor availability, The International Journal of Neuropsychopharmacology, 2013, 16, 04, 745

    CrossRef

  22. 22
    Axel Rominger, Paul Cumming, Guoming Xiong, Gabriele Koller, Guido Böning, Melanie Wulff, Andreas Zwergal, Stefan Förster, Anthonin Reilhac, Ole Munk, Michael Soyka, Björn Wängler, Peter Bartenstein, Christian la Fougère, Oliver Pogarell, [18F]fallypride PET measurement of striatal and extrastriatal dopamine D2/3 receptor availability in recently abstinent alcoholics, Addiction Biology, 2012, 17, 2
  23. 23
    Sarah A. Eisenstein, Jon M. Koller, Marilyn Piccirillo, Ana Kim, Jo Ann V. Antenor-Dorsey, Tom O. Videen, Abraham Z. Snyder, Morvarid Karimi, Stephen M. Moerlein, Kevin J. Black, Joel S. Perlmutter, Tamara Hershey, Characterization of extrastriatal D2 in vivo specific binding of [18F](N-methyl)benperidol using PET, Synapse, 2012, 66, 9
  24. 24
    Alessandro Colasanti, Graham E. Searle, Christopher J. Long, Samuel P. Hill, Richard R. Reiley, Darren Quelch, David Erritzoe, Andri C. Tziortzi, Laurence J. Reed, Anne R. Lingford-Hughes, Adam D. Waldman, Koen R.J. Schruers, Paul M. Matthews, Roger N. Gunn, David J. Nutt, Eugenii A. Rabiner, Endogenous Opioid Release in the Human Brain Reward System Induced by Acute Amphetamine Administration, Biological Psychiatry, 2012, 72, 5, 371

    CrossRef

  25. 25
    Nina B.L. Urban, Diana Martinez, Neurobiology of Addiction, Psychiatric Clinics of North America, 2012, 35, 2, 521

    CrossRef

  26. 26
    Karmen K. Yoder, Bruce H. Mock, Qi-Huang Zheng, Brian P. McCarthy, Amanda A. Riley, Gary D. Hutchins, Assessment of IP injection of [18F]fallypride for behavioral neuroimaging in rats, Journal of Neuroscience Methods, 2011, 196, 1, 70

    CrossRef

  27. 27
    Noah Meyers, Stephen Fromm, David A. Luckenbaugh, Wayne C. Drevets, Gregor Hasler, Neural correlates of sleepiness induced by catecholamine depletion, Psychiatry Research: Neuroimaging, 2011, 194, 1, 73

    CrossRef

  28. 28
    Katja N. Spreckelmeyer, Michael Paulzen, Mardjan Raptis, Thomas Baltus, Sabrina Schaffrath, Julia Van Waesberghe, Magdalena M. Zalewski, Frank Rösch, Ingo Vernaleken, Wolfgang M. Schäfer, Gerhard Gründer, Opiate-Induced Dopamine Release Is Modulated by Severity of Alcohol Dependence: An [18F]Fallypride Positron Emission Tomography Study, Biological Psychiatry, 2011, 70, 8, 770

    CrossRef

  29. 29
    Sari Karlsson, Anna Rieckmann, Per Karlsson, Lars Farde, Lars Nyberg, Lars Bäckman, Relationship of dopamine D1 receptor binding in striatal and extrastriatal regions to cognitive functioning in healthy humans, NeuroImage, 2011, 57, 2, 346

    CrossRef

  30. 30
    Natalia del Campo, Samuel R. Chamberlain, Barbara J. Sahakian, Trevor W. Robbins, The Roles of Dopamine and Noradrenaline in the Pathophysiology and Treatment of Attention-Deficit/Hyperactivity Disorder, Biological Psychiatry, 2011, 69, 12, e145

    CrossRef

  31. 31
    Christian Landvogt, Hans-Georg Buchholz, Viviane Bernedo, Mathias Schreckenberger, Konrad J. Werhahn, Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy, Epilepsia, 2010, 51, 9
  32. 32
    Axel Rominger, Erika Wagner, Erik Mille, Guido Böning, Mouna Esmaeilzadeh, Björn Wängler, Franz-Josef Gildehaus, Sebastian Nowak, Ariane Bruche, Klaus Tatsch, Peter Bartenstein, Paul Cumming, Endogenous competition against binding of [18F]DMFP and [18F]fallypride to dopamine D2/3 receptors in brain of living mouse, Synapse, 2010, 64, 4
  33. 33
    Marta G. Vučcković, Quanzheng Li, Beth Fisher, Angelo Nacca, Richard M. Leahy, John P. Walsh, Jogesh Mukherjee, Celia Williams, Michael W. Jakowec, Giselle M. Petzinger, Exercise elevates dopamine D2 receptor in a mouse model of Parkinson's disease: In vivo imaging with [18F]fallypride, Movement Disorders, 2010, 25, 16
  34. 34
    Ningning Guo, Wen Guo, Michaela Kralikova, Man Jiang, Ira Schieren, Raj Narendran, Mark Slifstein, Anissa Abi-Dargham, Marc Laruelle, Jonathan A Javitch, Stephen Rayport, Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers, Neuropsychopharmacology, 2010, 35, 3, 806

    CrossRef

  35. 35
    W. Gordon Frankle, N. Scott Mason, Eugenii A. Rabiner, Khanum Ridler, Maureen A. May, Deanna Asmonga, Chi-Min Chen, Steve Kendro, Thomas B. Cooper, Chester A. Mathis, Rajesh Narendran, No effect of dopamine depletion on the binding of the high-affinity D2/3 radiotracer [11C]FLB 457 in the human cortex, Synapse, 2010, 64, 12
  36. 36
    Mark Slifstein, Lawrence S. Kegeles, Xiaoyan Xu, Judy L. Thompson, Nina Urban, John Castrillon, Elizabeth Hackett, S.-A. Bae, Marc Laruelle, Anissa Abi-Dargham, Striatal and extrastriatal dopamine release measured with PET and [18F] fallypride, Synapse, 2010, 64, 5
  37. 37
    David H. Zald, Neil D. Woodward, Ronald L. Cowan, Patrizia Riccardi, M. Sib Ansari, Ronald M. Baldwin, Ronald L. Cowan, Clarence E. Smith, Helene Hakyemez, Rui Li, Robert M. Kessler, The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: A principal component analysis of [18F]fallypride binding, NeuroImage, 2010, 51, 1, 53

    CrossRef

  38. 38
    Sandra E Leh, Michael Petrides, Antonio P Strafella, The Neural Circuitry of Executive Functions in Healthy Subjects and Parkinson's Disease, Neuropsychopharmacology, 2010, 35, 1, 70

    CrossRef

  39. 39
    Ingo Vernaleken, Jens Kuhn, Doris Lenartz, Mardjan Raptis, Wolfgang Huff, Hildegard Janouschek, Irene Neuner, Wolfgang M. Schaefer, Gerhard Gründer, Volker Sturm, Bithalamical Deep Brain Stimulation in Tourette Syndrome Is Associated with Reduction in Dopaminergic Transmission, Biological Psychiatry, 2009, 66, 10, e15

    CrossRef

  40. 40
    Peter Kletting, Thomas Kull, Sven N Reske, Gerhard Glatting, Comparing time activity curves using the Akaike information criterion, Physics in Medicine and Biology, 2009, 54, 21, N501

    CrossRef

  41. 41
    Arkadij M. Elizarov, Microreactors for radiopharmaceutical synthesis, Lab on a Chip, 2009, 9, 10, 1326

    CrossRef

  42. 42
    Rajesh Narendran, W. Gordon Frankle, N. Scott Mason, Eugenii A. Rabiner, Roger N. Gunn, Graham E. Searle, Shivangi Vora, Maralee Litschge, Steve Kendro, Thomas B. Cooper, Chester A. Mathis, Marc Laruelle, Positron emission tomography imaging of amphetamine-induced dopamine release in the human cortex: A comparative evaluation of the high affinity dopamine D2/3 radiotracers [11C]FLB 457 and [11C]fallypride, Synapse, 2009, 63, 6
  43. 43
    Sargo Aalto, Jussi Hirvonen, Valtteri Kaasinen, Nora Hagelberg, Jaana Kajander, Kjell Någren, Timo Seppälä, Juha O. Rinne, Harry Scheinin, Jarmo Hietala, The effects of d-amphetamine on extrastriatal dopamine D2/D3 receptors: a randomized, double-blind, placebo-controlled PET study with [11C]FLB 457 in healthy subjects, European Journal of Nuclear Medicine and Molecular Imaging, 2009, 36, 3, 475

    CrossRef

  44. 44
    Henning Boecker, Gjermund Henriksen, Till Sprenger, Isabelle Miederer, Frode Willoch, Michael Valet, Achim Berthele, Thomas R. Tölle, Positron emission tomography ligand activation studies in the sports sciences: Measuring neurochemistry in vivo, Methods, 2008, 45, 4, 307

    CrossRef